Shandong Ruifeng Chemical Co., Ltd. (SHE:300243)
China · Delayed Price · Currency is CNY 12.53
-0.05 (-0.40%)
Feb 27, 2026, 3:04 PM CST
Shandong Ruifeng Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,999 | 1,999 | 1,772 | 1,830 | 1,852 | 1,297 |
Other Revenue | 2.25 | 2.25 | 3.83 | 1.85 | 6.7 | 5.1 |
| 2,001 | 2,001 | 1,776 | 1,832 | 1,858 | 1,302 | |
Revenue Growth (YoY) | 3.70% | 12.66% | -3.03% | -1.45% | 42.75% | 7.29% |
Cost of Revenue | 1,718 | 1,719 | 1,468 | 1,537 | 1,517 | 1,029 |
Gross Profit | 282.73 | 282.03 | 308.24 | 294.44 | 341.48 | 272.42 |
Selling, General & Admin | 197 | 186.03 | 187.34 | 209.92 | 182.22 | 154.02 |
Research & Development | 7.11 | 9.01 | 14.6 | 6.43 | 4.31 | 4.32 |
Other Operating Expenses | 2.23 | 4.33 | 1.09 | 6.65 | 5.51 | 6.29 |
Operating Expenses | 209.68 | 204.56 | 202.61 | 223.19 | 193.12 | 164.43 |
Operating Income | 73.05 | 77.47 | 105.63 | 71.26 | 148.36 | 107.99 |
Interest Expense | -44.23 | -41.78 | -22.58 | -21.23 | -20.71 | -11.74 |
Interest & Investment Income | 4.15 | 3.53 | 4.07 | 1.11 | 5.39 | 0.22 |
Earnings From Equity Investments | -0.43 | -0.43 | 0.02 | - | - | - |
Currency Exchange Gain (Loss) | 5.37 | 5.37 | 3.15 | 6.99 | -1.61 | -2.34 |
Other Non Operating Income (Expenses) | -3.36 | -1.89 | 0.53 | -3.57 | -3.18 | -0.61 |
EBT Excluding Unusual Items | 34.54 | 42.27 | 90.82 | 54.56 | 128.26 | 93.52 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.19 | 0.19 | -0.05 | 0.4 |
Asset Writedown | -12.36 | -14.48 | -3.2 | -7.84 | - | - |
Other Unusual Items | 2.42 | 4.47 | 2.18 | 25.07 | -21.67 | 5.98 |
Pretax Income | 24.65 | 32.27 | 89.99 | 71.98 | 106.53 | 99.9 |
Income Tax Expense | 15.48 | 10.56 | 4.71 | 10.84 | 15.49 | 15.34 |
Earnings From Continuing Operations | 9.16 | 21.72 | 85.28 | 61.14 | 91.05 | 84.56 |
Minority Interest in Earnings | 0.71 | 0.36 | 0.02 | - | 1.82 | 0.79 |
Net Income | 9.88 | 22.08 | 85.29 | 61.14 | 92.87 | 85.35 |
Net Income to Common | 9.88 | 22.08 | 85.29 | 61.14 | 92.87 | 85.35 |
Net Income Growth | -82.30% | -74.12% | 39.51% | -34.17% | 8.80% | 14.53% |
Shares Outstanding (Basic) | 221 | 221 | 237 | 235 | 232 | 231 |
Shares Outstanding (Diluted) | 221 | 221 | 237 | 235 | 238 | 231 |
Shares Change (YoY) | -9.13% | -6.82% | 0.76% | -1.25% | 3.22% | -0.95% |
EPS (Basic) | 0.04 | 0.10 | 0.36 | 0.26 | 0.40 | 0.37 |
EPS (Diluted) | 0.04 | 0.10 | 0.36 | 0.26 | 0.39 | 0.37 |
EPS Growth | -80.53% | -72.22% | 38.46% | -33.33% | 5.41% | 15.63% |
Free Cash Flow | 52.47 | -92.5 | -57.1 | -184.93 | -160.44 | -83.95 |
Free Cash Flow Per Share | 0.24 | -0.42 | -0.24 | -0.79 | -0.67 | -0.36 |
Dividend Per Share | 0.050 | 0.050 | 0.100 | - | 0.120 | 0.120 |
Dividend Growth | -50.00% | -50.00% | - | - | - | 20.00% |
Gross Margin | 14.13% | 14.10% | 17.36% | 16.08% | 18.38% | 20.93% |
Operating Margin | 3.65% | 3.87% | 5.95% | 3.89% | 7.98% | 8.29% |
Profit Margin | 0.49% | 1.10% | 4.80% | 3.34% | 5.00% | 6.56% |
Free Cash Flow Margin | 2.62% | -4.62% | -3.21% | -10.10% | -8.63% | -6.45% |
EBITDA | 192.15 | 170.31 | 163.45 | 124.54 | 189.04 | 142.32 |
EBITDA Margin | 9.60% | 8.51% | 9.20% | 6.80% | 10.17% | 10.93% |
D&A For EBITDA | 119.1 | 92.84 | 57.82 | 53.28 | 40.67 | 34.33 |
EBIT | 73.05 | 77.47 | 105.63 | 71.26 | 148.36 | 107.99 |
EBIT Margin | 3.65% | 3.87% | 5.95% | 3.89% | 7.98% | 8.29% |
Effective Tax Rate | 62.82% | 32.70% | 5.24% | 15.06% | 14.54% | 15.35% |
Revenue as Reported | 2,001 | 2,001 | 1,776 | 1,832 | 1,858 | 1,302 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.